A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients. - Wikidata - awgldk - TriplyDB

A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients.

A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients.

http://www.wikidata.org/entity/Q34721998

about

Proteomic analysis of cap-dependent translation identifies LARP1 as a key regulator of 5'TOP mRNA translation C8orf4 negatively regulates self-renewal of liver cancer stem cells via suppression of NOTCH2 signalling Translational progress on tumor biomarkers Coordination of nutrient availability and utilization by MAX- and MLX-centered transcription networks Prognostic biomarkers for prediction of recurrence of hepatocellular carcinoma: current status and future prospects The La-related protein 1-specific domain repurposes HEAT-like repeats to directly bind a 5'TOP sequence Integrative genomic identification of genes on 8p associated with hepatocellular carcinoma progression and patient survival P2X3 purinergic receptor overexpression is associated with poor recurrence-free survival in hepatocellular carcinoma patients One-step extrapolation of the prediction performance of a gene signature derived from a small study Recombinant human acid sphingomyelinase as an adjuvant to sorafenib treatment of experimental liver cancer Xmrk, kras and myc transgenic zebrafish liver cancer models share molecular signatures with subsets of human hepatocellular carcinoma Identifying prognostic features by bottom-up approach and correlating to drug repositioning A novel KLF6-Rho GTPase axis regulates hepatocellular carcinoma cell migration and dissemination Bioinformatics analysis of the proteins interacting with LASP-1 and their association with HBV-related hepatocellular carcinoma.Inhibition of hepatic lipogenesis enhances liver tumorigenesis by increasing antioxidant defence and promoting cell survival.An oncogenic role of Agrin in regulating focal adhesion integrity in hepatocellular carcinoma Development of biomarkers for screening hepatocellular carcinoma using global data mining and multiple reaction monitoring.Hepatocellular Carcinomas Originate Predominantly from Hepatocytes and Benign Lesions from Hepatic Progenitor Cells.Mutations acquired by hepatocellular carcinoma recurrence give rise to an aggressive phenotype.Roles of neutrophil gelatinase-associated lipocalin (NGAL) in human cancer.Systematic analysis of gene expression alterations and clinical outcomes of adenylate cyclase-associated protein in cancer.PLCE1 polymorphisms and expression combined with serum AFP level predicts survival of HBV-related hepatocellular carcinoma patients after hepatectomy.Prognostic Biomarker Identification Through Integrating the Gene Signatures of Hepatocellular Carcinoma Properties Application of microRNA and mRNA expression profiling on prognostic biomarker discovery for hepatocellular carcinoma Sixty-five gene-based risk score classifier predicts overall survival in hepatocellular carcinoma.PKM2 promotes cell migration and inhibits autophagy by mediating PI3K/AKT activation and contributes to the malignant development of gastric cancer.Clinical significance of the correlation between PLCE 1 and PRKCA in esophageal inflammation and esophageal carcinoma.Development and Validation of a Three-gene Prognostic Signature for Patients with Hepatocellular Carcinoma Transposon mutagenesis identifies genes driving hepatocellular carcinoma in a chronic hepatitis B mouse model Modulation of miR-29 expression by α-fetoprotein is linked to the hepatocellular carcinoma epigenome.KPT-330 inhibitor of XPO1-mediated nuclear export has anti-proliferative activity in hepatocellular carcinoma.Metabolic profiles are principally different between cancers of the liver, pancreas and breast.Expression profiling of mitochondrial voltage-dependent anion channel-1 associated genes predicts recurrence-free survival in human carcinomas Deciphering cancer heterogeneity: the biological space.Krüppel-like factor 4, a tumor suppressor in hepatocellular carcinoma cells reverts epithelial mesenchymal transition by suppressing slug expression.Loss of imprinting and allelic switching at the DLK1-MEG3 locus in human hepatocellular carcinoma.A feedback inhibition between miRNA-127 and TGFβ/c-Jun cascade in HCC cell migration via MMP13 Regulation of gene expression in HBV- and HCV-related hepatocellular carcinoma: integrated GWRS and GWGS analyses Integrative genomic and transcriptomic characterization of matched primary and metastatic liver and colorectal carcinoma.Regulation of glucose metabolism in hepatocarcinogenesis by microRNAs.

P2860

Q24337405-D5852B85-09A1-4966-AF17-71A4C7E59FF1 Q24337647-C561DBDC-5B60-46D3-B6A6-B3A4F704B386 Q26777676-EBBF8A02-3C6B-4D96-AA0B-CB29C9F085F4 Q26853482-700BB555-BA81-4E1B-B129-9FCF617815D9 Q27021265-8B4E1E6B-D670-43F7-9059-4B964596829B Q28114864-D7646A5D-AF93-43EA-8000-9524CFD541B7 Q28383106-42622AE7-8523-408C-90BD-786C8E78B801 Q28386398-B466272E-E9D1-4A74-A8B6-9799A7BB7795 Q28392088-4CCCB722-11EE-4336-85CE-F79B6F85B29C Q28533335-76F687CC-165C-4A4A-AB85-CEE0886C2074 Q28540910-8BE96854-D334-465C-A8CA-01D213F26E59 Q28543844-FC216BA2-9B7D-4C9A-9F42-327DCAB27B64 Q28597820-923E1D58-6086-404E-893A-9C3C310F98B3 Q30008764-CE2F6507-2A8A-4FE1-A2AF-E0C721084397 Q30252965-3A9C902E-EE88-48B1-B848-DDBB6742C29C Q30619662-C45C2C61-EEDB-4C2D-9F4D-78471E82B6E8 Q30635373-EA304E11-A6CA-489F-A186-D491E02D8733 Q33617469-C6029F30-CEEB-4495-983F-8AF8BBAF3251 Q33618512-F76BF2B9-D6FC-4430-A5AE-BFA5354B47B1 Q33688934-1D7A52A3-66A1-45D4-B139-E241F27AF322 Q33688989-7D0F88E7-A954-4040-8AA1-67696A1123B5 Q33710068-C76093B3-0FA9-4FFD-9D64-6E539D962E0B Q33715750-D5C5C7CE-0933-49D7-8BEB-9E01544F0A9D Q33715938-EA8E134F-80E1-4E9B-9847-6AD554E46809 Q33766930-CF357B82-7FD4-43D4-90B9-E31083E3AF3E Q33767514-319C1368-1CD8-42BE-A93E-E30E72A6C373 Q33779451-F8E1F4FB-0827-486C-BD18-3281BABCFE6D Q33911829-F5D75EC3-2F77-450D-8F2D-FDFE2209694B Q34038257-B9322131-E645-4E5D-8A1F-7C52E212AB32 Q34098359-4424BD8F-A4C7-42AA-AD4C-D1EEB01D9D28 Q34098446-FCAB64CE-C203-4A3D-9D4D-243A4BBB0A5F Q34157807-70A4D11C-129D-48B2-B280-9376F6A685D2 Q34344405-A103855E-37A3-4A4B-AD9F-89D1BF4993E3 Q34391327-06A166BC-E18A-4040-A681-E9875EBC0712 Q34399237-2D9F9479-BC21-4AA2-966E-2C72ED9614B6 Q34474525-B8B819D0-C2B2-4AB6-9B57-5145B22EAF66 Q34769755-B3ECEEAB-0C58-4A4D-84D8-60988CF8A8E1 Q34769837-74AB34E7-8DE6-4F3D-9EC4-703BB7E3AF3B Q34780974-4C81051E-7A29-48E2-905B-6C9B6E5C9743 Q34803043-BB019F4A-E161-46C9-8B97-E2FB14D921FF

P2860

A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients.

http://www.wikidata.org/entity/Q34721998

description

2010 nî lūn-bûn

@nan

2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

A unique metastasis gene signa ...... tocellular carcinoma patients.

@ast

A unique metastasis gene signa ...... tocellular carcinoma patients.

@en

A unique metastasis gene signa ...... tocellular carcinoma patients.

@nl

type

label

A unique metastasis gene signa ...... tocellular carcinoma patients.

@ast

A unique metastasis gene signa ...... tocellular carcinoma patients.

@en

A unique metastasis gene signa ...... tocellular carcinoma patients.

@nl

prefLabel

A unique metastasis gene signa ...... tocellular carcinoma patients.

@ast

A unique metastasis gene signa ...... tocellular carcinoma patients.

@en

A unique metastasis gene signa ...... tocellular carcinoma patients.

@nl

P1433

Q34721998-22042EEE-0FBE-43B9-A7C2-644DAC140D9E

P1476

Q34721998-5F2CF348-D83B-44BD-AAAD-F723A3988612

P2093

Q34721998-0D893518-266E-4BE8-82B8-70628EC39C9B

Q34721998-162B01A9-A2BC-4FAF-827B-2D0F989AB6AB

Q34721998-193FAFA4-ED71-4B42-9C30-E76982B608DA

Q34721998-211F7B47-AD60-4B90-A5BD-E2889C30BADE

Q34721998-4C3C9B85-7642-490A-BCB4-5CF5DDBE004C

Q34721998-9B033739-5E72-4AC6-AE1C-9FA55177CC5D

Q34721998-AA6AAE35-5A94-4666-A3D9-558401842887

Q34721998-BA14F984-4BEE-49FD-9373-410CC2002D7E

Q34721998-BB463D70-EF2D-4DFF-A3E3-070F6A0BDA7B

Q34721998-D7FD3237-A959-4F4B-850E-F5950C828961

P2860

Q34721998-269FD4DD-0033-4A68-97DC-E1ED643CDF35

Q34721998-2FF5719A-2481-4295-B6D9-C46897306B47

Q34721998-3327339A-3684-48AB-BC36-AA5AFAA2B9DF

Q34721998-36224BB8-C7C9-48BA-BF38-E6BE715B212F

Q34721998-37FCEAD8-93E9-4196-ADBD-ECDAEF577F6E

Q34721998-3E522D61-C808-4E56-B81D-091B7CCD36A6

Q34721998-4279C9C1-C530-4CA2-AACF-70AE958EC874

Q34721998-4AE5660E-AA1B-4D28-BCD3-0139C14B0D10

Q34721998-4DCE3A85-1367-47D2-9916-7D11CE1390BD

Q34721998-50A05F93-59D7-4E3B-8AFF-8B27E9E0A0DC

P304

Q34721998-E374DC93-0F2B-4194-B325-5C1A61AFE68D

P31

Q34721998-D57E2959-8F15-46BE-B8D1-7213B3A13BE4

P356

Q34721998-3C5630F4-DA41-425E-950F-1C3941DC8395

P407

Q34721998-A763C8CD-7C80-4B0F-B6FC-1C67DE70C2A4

P433

Q34721998-40524E35-D2F3-46E3-99A6-345E2F622C78

P478

Q34721998-D9F9BE43-B7A9-4F87-B996-323697AA91A6

P50

Q34721998-91D4810D-B31E-46B5-8B07-DD22194A4AA0

P577

Q34721998-B294D515-A904-4551-A2B4-45F69A25B7BF

P698

Q34721998-94D440AF-F973-4F2F-AC3C-C193E203882A

P932

Q34721998-4DB3A3AB-C2FF-4066-A9CF-DBE044699604

P356

0008-5472.CAN-10-2607

P1433

Cancer Research

P1476

A unique metastasis gene signa ...... atocellular carcinoma patients

@en

P2093

Anuradha Budhu

http://www.w3.org/2001/XMLSchema#string

Hu-Liang Jia

http://www.w3.org/2001/XMLSchema#string

Ju-Seog Lee

http://www.w3.org/2001/XMLSchema#string

Lun-Xiu Qin

http://www.w3.org/2001/XMLSchema#string

Marshonna Forgues

http://www.w3.org/2001/XMLSchema#string

Qing-Hai Ye

http://www.w3.org/2001/XMLSchema#string

Snorri S Thorgeirsson

http://www.w3.org/2001/XMLSchema#string

Xin Wei Wang

http://www.w3.org/2001/XMLSchema#string

Zhao-You Tang

http://www.w3.org/2001/XMLSchema#string

Zhongtang Sun

http://www.w3.org/2001/XMLSchema#string

P2860

The Hallmarks of Cancer

MicroRNA expression, survival, and response to interferon in liver cancer

Cancer statistics, 2008

A gene-expression signature as a predictor of survival in breast cancer

Sorafenib in advanced hepatocellular carcinoma

Exploration, normalization, and summaries of high density oligonucleotide array probe level data

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited

P304

10202-10212

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-10-2607

http://www.w3.org/2001/XMLSchema#string

P407

P433

24

http://www.w3.org/2001/XMLSchema#string

P478

70

http://www.w3.org/2001/XMLSchema#string

P50

Stephanie Roessler

P577

2010-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21159642

http://www.w3.org/2001/XMLSchema#string

P932

3064515

http://www.w3.org/2001/XMLSchema#string